Work

Supplementary Data from ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors

Year: 2023

Type: supplementary-materials

Abstract: The supplementary figures provide data supporting the combination drug screening process that uncovered synergy between PDI and HDAC inhibitors, and further supplements the findings in the main figures demonstrating the genomic, biochemical, and cellular characterization of the molecular mechanisms responsible for that synergy.

DOI: 10.1158/0008-5472.22426296

Authors: Ravyn M. Duncan, Leticia Reyes, Katelyn Moats, Reeder M. Robinson, Sara A. Murphy, Balveen Kaur, Holly A.F. Stessman, Nathan G. Dolloff

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362374914

Cites:

Cited by:

Related to: 10